Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaote’s radiology and
Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaotes radiology and shared service markets product line. The unit carries a fully digital beamformer and proprietary microchip circuitry, as well as new probe technology that maximizes the lateral resolution of Technos wideband multifrequency transducers. Technos combines color Doppler and power Doppler technology, and runs on a Windows NT operating system.
In other Esaote news, the company celebrated the sale of its 500th dedicated MRI system, which it has achieved through sales of both Artoscan and E-Scan, an open-style, 0.2-tesla MRI scanner dedicated to orthopedic studies. E-Scan was cleared by the Food and Drug Administration in June (SCAN 6/23/99).
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.